Description
An adenosine receptor antagonist (IC50s = 3.5, 4.2, 16, and 51 nM for human recombinant A1, A2A, A2B, and A3 receptors); binds p100γ and inhibits proliferation of HCC and PDAC cells through the PI3K/Akt signaling pathway; increases locomotor activity in rats in a dose-dependent manner; reinforces and reinstates cocaine-seeking in baboons,
Formal name: 9-chloro-2-(2-furanyl)-[1,2,4]triazolo[1,5-c]quinazolin-5-amine
Synonyms: CGS 15943A
Molecular weight: 285.7
CAS: 104615-18-1
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research